Vernakalant hydrochloride for rapid conversion of atrial fibrillation. A phase 3, randomized, placebo-controlled trial

被引：0
|
作者：
Estes, N. A. Mark, III [1 ]
机构：
[1] Tufts Univ, Sch Med, Dept Med, Div Cardiol,New England Cardiac Arrhythmia Ctr, Boston, MA 02111 USA
来源：
HEART RHYTHM | 2008年 / 5卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：906 / 906
页数：1
相关论文
共 50 条
  • [1] Vernakalant hydrochloride for rapid conversion of atrial fibrillation - A phase 3, randomized, placebo-controlled trial
    Roy, Denis
    Pratt, Craig M.
    Torp-Pedersen, Christian
    Wyse, D. George
    Toft, Egon
    Juul-Moller, Steen
    Nielsen, Tonny
    Rasmussen, S. Lind
    Stiell, Ian G.
    Coutu, Benoit
    Ip, John H.
    Pritchett, Edward L. C.
    Camm, A. John
    CIRCULATION, 2008, 117 (12) : 1518 - 1525
  • [2] Vernakalant Hydrochloride for the Rapid Conversion of Atrial Fibrillation After Cardiac Surgery A Randomized, Double-Blind, Placebo-Controlled Trial
    Kowey, Peter R.
    Dorian, Paul
    Mitchell, L. Brent
    Pratt, Craig M.
    Roy, Denis
    Schwartz, Peter J.
    Sadowski, Jerzy
    Sobczyk, Dorota
    Bochenek, Andrzej
    Toft, Egon
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2009, 2 (06): : 652 - 659
  • [3] Usefulness of Vernakalant Hydrochloride Injection for Rapid Conversion of Atrial Fibrillation
    Pratt, Craig M.
    Roy, Denis
    Torp-Pedersen, Christian
    Wyse, D. George
    Toft, Egon
    Juul-Moller, Steen
    Retyk, Enrique
    Drenning, David Humphrey
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (09): : 1277 - 1283
  • [4] Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
    Gregory N. Beatch
    Brian Mangal
    BMC Cardiovascular Disorders, 16
  • [5] Safety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trial
    Beatch, Gregory N.
    Mangal, Brian
    BMC CARDIOVASCULAR DISORDERS, 2016, 16
  • [6] A Randomized, Placebo-Controlled Study of Vernakalant (Oral) for the Prevention of Atrial Fibrillation Recurrence After Cardioversion
    Torp-Pedersen, Christian
    Raev, Dimitar H.
    Dickinson, Garth
    Butterfield, Noam N.
    Mangal, Brian
    Beatch, Gregory N.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2011, 4 (05): : 637 - 643
  • [7] Intravenous propafenone versus digoxin in recent onset atrial fibrillation. A placebo-controlled, randomized study
    Bianconi, L
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) : 370A - 370A
  • [8] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
    Camm, A. John
    Toft, Egon
    Torp-Pedersen, Christian
    Vijayaraman, Pugazhendhi
    Juul-Moller, Steen
    Ip, John
    Beatch, Gregory N.
    Dickinson, Garth
    Wyse, D. George
    EUROPACE, 2012, 14 (06): : 804 - 809
  • [9] Pharmacological conversion of recent atrial fibrillation: a randomized, placebo-controlled study of three antiarrhythmic drugs
    Balla, Idriz
    Petrela, Elizana
    Kondili, Anesti
    ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2011, 11 (07): : 600 - 606
  • [10] Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial
    Benz, Alexander P.
    Amit, Guy
    Connolly, Stuart J.
    Singh, Jasrita
    Acosta-Velez, Juan G.
    Conen, David
    Deif, Bishoy
    Divakaramenon, Syamkumar
    McIntyre, William F.
    Mtwesi, Viwe
    Roberts, Jason D.
    Wong, Jorge A.
    Zhao, Robin
    Healey, Jeff S.
    CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2024, 17 (01): : 2 - 10
12345